Market Tracker

05/26 5:16pm ET

TG Therapeutics Inc (NASDAQ:TGTX)

12.05
Delayed Data
As of May 26
 +0.15 / +1.26%
Today’s Change
4.10
Today|||52-Week Range
15.05
+159.14%
Year-to-Date
5 Stocks Setting Up for Big Breakouts
May 26 / TheStreet.com - Paid Partner Content
TG Therapeutics Stock Climbs After Successfully Completed Analysis in UNITY-CLL
May 23 / TheStreet.com - Paid Partner Content
The Machines Are Sapping the Fun out of This Day
May 26 / TheStreet.com - Paid Partner Content
Shark Bites: There Wasn't Even a Dip to Buy
May 23 / TheStreet.com - Paid Partner Content
Biotech Needs a Shot in the Arm
May 26 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close11.90
Today’s open11.90
Day’s range11.80 - 12.55
Volume1,266,542
Average volume (3 months)1,893,501
Market cap$804.6M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-15.94%
Earnings growth (this year)-7.08%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,496.53
Price/Book19.08

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc-0.29-6.79%
ALDRAlder Biopharmaceuti...-0.90-5.28%
BHVNBiohaven Pharmaceuti...+0.82+3.57%
SGYPSynergy Pharmaceutic...-0.21-5.69%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateAugust 7, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$152.4K
Annual profit (last year)-$78.3M
Net profit margin-51,353.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
Chief Financial Officer, Secretary &
Treasurer
Sean A. Power
Corporate headquarters
New York, New York

Forecasts